|

Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Children's Hospital Medical Center, Cincinnati1

Indications

  • B-cell Acute Lymphoblastic Leukemia1
  • Cancer1

Cincinnati, Ohio1 trial

Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

Cincinnati Children's Hospital Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.